Business Wire

AGC’s Group Company in Southeast Asia Obtains International Sustainability and Carbon Certification, “ISCC PLUS Certification”

Share

AGC (AGC Inc., Headquarters: Tokyo; President: Yoshinori Hirai) (TOKYO:5201), a world-leading manufacturer of glass, chemicals and other high-tech materials, has announced that its group company PT Asahimas Chemical (ASC, Headquarters: Indonesia), has recently obtained ISCC PLUS Certification*, one of the international certification systems for sustainable products. This certification confirms that biomass-derived raw materials and renewable raw materials (including those derived from renewable energy) are managed sustainably throughout the entire supply chain, including the manufacturing process, in accordance with ISCC standards, and that the traceability is ensured.

This certification enables ASC to handle ISCC PLUS-certified products such as Caustic soda, Vinyl chloride monomer (VCM), and Polyvinyl chloride resin (PVC), thereby strengthening its product portfolio. Additionally, ASC will be able to provide customers who are actively promoting sustainability with products that meet international standards. The following products in the Chemicals Segment of the AGC Group have currently obtained this certification.

Certified companies and sites

Representative products certified

Date of certification

PT Asahimas Chemical
  Anyer plant (Indonesia)

Caustic soda
Vinyl chloride monomer (VCM)
Polyvinyl chloride resin (PVC)
Hydrochloric acid
Sodium hypochlorite
Ethylene dichloride (EDC)

June 2025

AGC Vinythai Public Company Limited
  Map Ta Phut plant 1 (Thailand)

Epichlorohydrin "EPINITY™"

July 2023

Under its long-term management strategy "Vision 2030", the AGC Group has set "Sustainability Management" as one of its key strategies. By providing these certified products, the Group will promote initiatives that reduce environmental impact throughout the entire value chain - from the procurement of raw materials to customer use - thereby contributing to the realization of a sustainable global environment.

[Remark]
* ISCC (International Sustainability and Carbon Certification) PLUS Certification
https://www.iscc-system.org/certification/iscc-certification-schemes/iscc-plus/

View source version on businesswire.com: https://www.businesswire.com/news/home/20250727267568/en/

Contacts

MEDIA INQUIRIES
AGC Inc.
Corporate Communications & Investor Relations Division
Contact: info-pr(at)agc.com

Product inquires
AGC Inc.
Chemicals Company
Contact:
https://www.agc-chemicals.com/sg/en/inquiry/form.html?f_id=CHN-SG-EN-0001 -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.agc-chemic
als.com%2Fsg%2Fen%2Finquiry%2Fform.html%3Ff_id%3DCHN-SG-EN-0001&esheet=54296593&
newsitemid=20250727267568&lan=en-US&anchor=https%3A%2F%2Fwww.agc-chemicals.com%2
Fsg%2Fen%2Finquiry%2Fform.html%3Ff_id%3DCHN-SG-EN-0001&index=2&md5=821fbe64c90f9
a660923de7e20da2fa4

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Tractive Acquires Whistle from Mars Petcare to Accelerate Leadership in Global Pet Tech Market28.7.2025 14:00:00 EEST | Press release

Tractive, the global leader in GPS tracking and pet health insights, today announced it has acquired Whistle, the connected pet wearable brand owned by Mars Petcare. This strategic acquisition adds Whistle’s customer base and technology assets to Tractive, reinforcing its leadership in the fast-growing pet tech market. Founded in Austria in 2012, Tractive has established itself as the world's leading provider of smart GPS and health trackers for pets, serving over 1.4 million active users worldwide with millions of devices sold globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250728342394/en/ Whistle is now part of Tractive Whistle customers will have the option to transition to Tractive’s highly rated platform, named #1 by Consumer Reports and recognized as the top pet tracker on Amazon and top pick by The New York Times Wirecutter. The move gives Whistle users access to Tractive’s latest innovations, including rest

Deciphera Announces Positive CHMP Opinion for ROMVIMZA™ (vimseltinib) for the Treatment of Tenosynovial Giant Cell Tumor (TGCT)28.7.2025 14:00:00 EEST | Press release

Deciphera Pharmaceuticals, LLC, a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines, andOno Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of vimseltinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with clinically relevant physical function deterioration and in whom surgical options have been exhausted or would induce unacceptable morbidity or disability. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250725009938/en/ The positive CHMP opinion is a scientific recommendation for marketing authorization and one of the final steps before the European Commission (EC), which has the authority to approve

BeOne Medicines Receives Positive CHMP Opinion for TEVIMBRA ® in Neoadjuvant/Adjuvant NSCLC Treatment28.7.2025 13:00:00 EEST | Press release

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency issued a positive opinion recommending approval of TEVIMBRA® (tislelizumab), in combination with platinum-containing chemotherapy as neoadjuvant treatment and then continued as monotherapy as adjuvant treatment, for the treatment of adult patients with resectable non-small cell lung cancer (NSCLC) at high risk of recurrence. This recommendation is based on the Phase 3 RATIONALE-315 study (NCT04379635). “Patients with resectable, early-stage NSCLC face an urgent challenge – despite surgery and current therapies, recurrence rates remain alarmingly high,” said Dr. Mariano Provencio, Head of the Medical Oncology Department at Hospital Universitario Puerta de Hierro and Professor at the Faculty of Medicine of Universidad Autonoma de Madrid in Spain. “The significant clinical benefit observed i

L&T Technology Services Wins ~ $60 Million Software Engineering Engagement From US Tier-I Telecom Provider28.7.2025 10:30:00 EEST | Press release

L&T Technology Services Limited (BSE: 540115, NSE: LTTS), a global leader in engineering and technology services, today announced a major milestone in its Tech segment with the signing of a ~$60 million multi-year agreement with a prominent U.S. based provider of wireless telecommunications services. This strategic engagement will see LTTS delivering advanced network software development and application engineering solutions. Under the terms of the agreement, LTTS will provide crucial engineering services, including R&D lab integration, new product development, and functionality testing for the customer’s network software automation platforms. Additionally, LTTS will establish a delivery center in the United States to further support and enhance project delivery. The engagement will leverage LTTS’ capabilities in Smart World Connectivity and next generation networks to drive cutting-edge innovations for the client. This deal underscores the strength of the decade-long partnership betwe

Bureau Veritas Partners with IFC’s Building Resilience Index to Expand Resilience Verification Services Globally28.7.2025 09:00:00 EEST | Press release

Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC), has signed the first global verifier agreement to expand the reach and impact of the Building Resilience Index (BRI). Under this agreement, Bureau Veritas will serve as a verification partner for BRI across key emerging markets in Latin America, Africa, and East Asia and the Pacific. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250727906462/en/ Marc Roussel, Executive Vice President, Urbanization & Assurance at Bureau Veritas An innovation of IFC, a member of the World Bank Group, BRI is a web-based framework designed to help developers, investors, and policymakers identify risks to buildings posed by natural hazards and assess, improve, and disclose their resilience. Through this partnership with Bureau Veritas, BRI users will gain greater access to high-quality, third-party verification of climate-resilient construction practices, e

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye